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Randolph Y. Hampton
Transcriptional regulation and membrane traffic have
traditionally been quite separate fields of biology, but
they have been brought under the same roof by recent
advances in understanding the cellular control of
cholesterol metabolism.
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Mammalian cells tightly regulate the levels of many
proteins responsible for cholesterol synthesis and uptake
[1], including enzymes of sterol synthesis, such as HMG-
CoA reductase, and the LDL receptor that mediates endo-
cytosis of cholesterol-rich LDL particles. A substantial
component of this parallel regulation of sterol synthesis
and uptake occurs at the level of transcription. Abundant
cholesterol decreases transcription of the relevant target
genes, whereas a scarcity of cholesterol promotes their
transcription. This is only part of the fascinating biology of
sterol regulation, but the focus of this dispatch will be on
transcriptional regulation. For close to thirty years, Brown,
Goldstein and colleagues have been committed to under-
standing how sterols regulate transcription [2]. Their
studies have revealed an astonishing number of cellular
insights and unlikely connections. The latest surprise is an
unexpected link between transcriptional regulation and
cellular membrane traffic [3].
SREBP: ER bound for glory
The promoters of all sterol-regulated genes include a
regulatory sequence known as the sterol response element
(SRE), which will faithfully impart physiologically correct
cholesterol regulation to heterologous reporter genes. So
far, this sounds like any number of transcriptionally
regulated genes. But the identification and study of the
proteins responsible for transcription and sterol control
yielded unexpected connections to membrane traffic. As
might be expected, a transcription factor exists that specif-
ically binds SRE — not surprisingly, this is known as the
SRE binding protein (SREBP). The isolation of SREBP
was a prodigious task, requiring numerous approaches and
the efforts of many talented people [4]. 
There are actually two isoforms of this protein, SREBP1
and SREBP2, and three splice variants of isoform 1. All
have similar structure and behavior, and in this work we
will refer to a ‘consensus’ protein SREBP. SREBP has an
unusual structure that plays a central role in regulation [5]
(Figure 1). The amino-terminal half of SREBP is sufficient
to mediate SRE-dependent transcription, and the
sequence of this part of the protein shows that SREBP is a
member of the large basic-helix–loop–helix/leucine zipper
family of transcription factors. In the full-length protein,
this transcription factor region is connected to a membrane
anchor with two transmembrane spans, a small lumenal
loop, and a large cytosolic carboxy-terminal region. Full-
length SREBP is attached to the endoplasmic reticulum
(ER), with the amino-terminal region facing the cytosol.
The transcriptionally active amino-terminal portion of
SREBP must be cleaved from the membrane anchor in
order to enter the nucleus and activate transcription. It is
the production of this soluble, active form that is regulated
by sterols [4]. High cholesterol levels inhibit cleavage and so
decrease the amount of active, soluble SREBP, whereas low
cholesterol levels promote cleavage and so increase the
amount of soluble SREBP. Fancy, and novel. Release of the
amino-terminal region actually occurs by two proteolytic
cleavages at specific sites in the membrane-bound SREBP
[6]. The first cleavage takes place in the lumenal loop, and
the second occurs in the first membrane span, near enough
to the cytosolic face to release the soluble portion. Only the
first cleavage is regulated by sterols, and the second one can
only proceed after the first has taken place. 
Figure 1
Key players in cholesterol-regulated transcription. The proteins
SREBP, SCAP and S1P are shown with key features. SREBP: the
basic-helix–loop–helix (bHLH) region is an active transcription factor
when released from the ER membrane anchor. The carboxy-terminal
region mediates binding to SCAP. SCAP: the WD domain binds the
carboxy-terminal region of SREBP (C); the ‘birds feet’ represent
glycosylation sites that were important in initial formulation of the
regulated-transport model; and SSD is the sterol-sensing domain.
S1P: the bulk of the protein, including the protease catalytic region, is
in the ER lumen. In all cases, N and C refer to the amino terminus and
the carboxyl terminus, respectively.
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The identity of SREBP was brought to light by heroic
biochemistry. The other players (so far) in sterol-regulated
processing of SREBP were discovered through the use of
somatic cell genetics. Over the past 20 years, a variety of
mammalian cell lines have been derived with abnormal
cholesterol homeostasis. Analysis of these lines, along with
generation of new ones, led to identification of mutants
deficient in specific aspects of SREBP processing, includ-
ing the first, sterol-regulated cleavage [7], the second
cleavage [8], and the sterol regulation of normal cleavage
[9]. Through the use of thoroughly clever expression
cloning strategies, the wild-type gene defective in each
mutant line was cloned. These efforts identified the two
distinct membrane-bound proteases responsible for the
first and second cleavage reactions, called S1P and S2P,
respectively, and ‘SREBP cleavage activating protein’
(SCAP), the key protein in the coupling of SREBP cleav-
age rate to cellular levels of sterols.
SCAP: a guide to the Golgi
SCAP resides in the ER, and consists of a hydrophobic
amino-terminal domain with eight transmembrane spans,
and a carboxy-terminal region with five WD repeats [9]
(Figure 1). SCAP binds tightly to SREBP in vivo, through
interaction between the WD domains and the SREBP
carboxy-terminal region [10]. The membrane anchor of
SCAP has a region called the ‘sterol-sensing domain’ that
is implicated in cholesterol interactions in a variety of
proteins. The sterol-sensing domain of SCAP is required
for sterol-regulated cleavage of SREBP — a single
residue change in this region causes the sterol-insensitiv-
ity observed in the cell line from which SCAP was
cloned. The original model derived from these studies
was that SCAP orchestrates S1P-catalyzed cleavage of
SREBP by forming a complex whose efficiency is altered
by sterols [11].
A critical hint that things could actually be different arose
in the study of SCAP biochemistry [12,13]. SCAP has two
N-linked glycosylations on one of its lumenal loops
(Figure 1). Despite the bulk ER localization of SCAP,
these decorations are partially resistant to endoglycosidase
H, a biochemical hallmark of a visit to the early Golgi
compartment, and studies with inhibitors and other
enzymes confirmed that the unexpected endoglycosidase
H resistance is indeed due to Golgi enzymes. Further-
more, this biochemical feature of SCAP is affected by
cellular sterol content. When sterols are abundant, the
SCAP glycosylations are endoglycosidase H sensitive.
Conversely, when cellular sterols are low, SCAP glysosyla-
tions are modified to endoglycosidase H resistance by
Golgi enzymes. These observations were interpreted to
mean that SCAP cycles between the early Golgi and the
ER, and that high sterol content specifically blocks the
ER-to-Golgi movement of SCAP by interacting with, or
somehow affecting, the sterol-sensing domain (Figure 2a).
As mentioned above, SREBP resides in the ER. But as
shown by the recent work of DeBose-Boyd et al. [3], the
active form of S1P, called S1P-C, resides in a Golgi-like
compartment where it is activated. As SREBP binds to
SCAP, and SCAP cycles through the Golgi in a sterol-
regulated manner, it seemed possible that S1P cleavage of
SREBP could be regulated through SCAP-mediated
delivery of SREBP to the Golgi, where it would meet
active S1P. In the latest addition to the story, DeBose-
Boyd et al. [3] have tested these ideas with an elegant set
of experiments. The ‘escort’ model of SCAP action makes
several strong predictions. If SCAP serves only to bring
SREBP to the compartment where active S1P resides,
then bringing S1P to where most of the SREBP resides
should override both sterol regulation and SCAP-depen-
dence of SREBP processing.
S1P meets its match: location, location, location
This ‘mountain to Mohammed’ experiment was done both
by pharmacological and molecular biological means. The
drug brefeldin A (BFA) causes disassembly of the Golgi,
and rapid mixing of Golgi and ER contents. If exposure to
Golgi-localized S1P determines SREBP cleavage, then
BFA treatment should cause S1P-catalyzed cleavage
(Figure 2b). DeBose-Boyd et al. [3] found that indeed it
does — in fact, it causes complete processing of SREBP to
the active nuclear form. BFA-induced processing of
SREBP was unaffected by high sterol levels, and thus was
not regulated. Importantly, BFA-induced processing of
SREBP still occurred in a mutant cell line missing SCAP,
but failed to occur in a line missing S1P. Thus, SCAP was
not needed for SREBP processing in conditions where S1P
and SREBP were allowed to mingle.
To test if SREBP processing could be brought about by
mislocalization of only S1P, DeBose-Boyd et al. [3] took
advantage of a well-know cellular ‘traffic law’. The KDEL
— Lys-Asp-Glu-Leu — sequence is a luminal ER reten-
tion signal, which mediates retrieval of proteins from the
early Golgi and delivery back to the ER. The authors
engineered a modified version of S1P, S1P-KDEL,
consisting of the soluble, lumenal domain of S1P with an
added KDEL sequence at the carboxyl terminus. Because
of the added signal, S1P-KDEL goes to the Golgi to be
activated, but it ultimately resides in the ER (Figure 2c).
By the SCAP-traffic model, expression of S1P-KDEL
should allow SREBP processing that is not inhibited by
elevated sterols, and is not dependent on SCAP. And this
is exactly what was found to occur! Interestingly, mislocal-
ization of only active S1P to the ER results in complete
processing of SREBP, indicating that either some S2P
resides in the ER, or that S1P-cleaved SREBP can go to
where S2P does reside.
The work of DeBose-Boyd et al. [3] clearly shows that
exposure of SREBP to activated S1P is the critical event in
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cholesterol regulation of transcription. SCAP’s role appears
to be to ferry SREBP to this protease, and neither choles-
terol nor SCAP seem to be involved with either cleavage.
There are several important issues to be explored in the
framework of this new model. The view that SREBP is
moved to the Golgi where it is exposed to active S1P is
quite reasonable, as the bulk of active S1P appears to
reside in the Golgi, the bulk of SREBP resides in the ER,
SCAP moves between them in a sterol-regulated manner,
and SCAP binds SREBP but apparently not S1P.
Nevertheless, it still is possible that molecules of active,
Golgi-resident S1P are moved to the ER by SCAP, and effi-
ciently directed to SREBP by SCAP’s ability to bind the
substrate. It will be important to directly examine the trans-
port of SREBP, either by biochemical or other means, as a
key test of the favored — SREBP to Golgi — model. A
related question concerns the fate of the cleaved, carboxy-
terminal portion of SREBP. Does it move to the Golgi?
Does it ride back to the ER with SCAP? Or is it perhaps
degraded by the secretory pathway quality-control mecha-
nisms? This is a potentially important question, as an excess
of the leftover carboxy-terminal region could possibly
compete with full-length SREBP for binding to SCAP, as it
does when produced by molecular biological means [10]. 
Understanding the controlled transit of SCAP and SREBP
(or S1P?) is likely to provide many important insights rele-
vant to cholesterol regulation, and will address numerous
issues of specificity and targeting in membrane traffic. It
would be quite impressive and useful to harness the newly
available optical tools — such as green fluorescent protein
(GFP) and deconvoluting confocal microscopy — to
directly observe sterol-regulated transport in vivo.
Where SCAP might take us: from sterols to soil, and beyond
The sterol-sensing domain appears to contain information
that mediates cholesterol regulation of SCAP. Related
sterol-sensing domains are found in several other proteins
associated with cholesterol [14]. These include the sterol-
synthetic enzyme HMG-CoA reductase [15], the
hedgehog receptor Patched and its homologue Dispatched
[16–18], and the Neimann-Pick C1 gene product [19,20].
How does the sterol sensing-domain operate? Proteins
with sterol-sensing domains seem to have quite varied
connections to cholesterol: SCAP undergoes altered intra-
cellular transport; HMG-CoA reductase is subjected to
sterol-regulated degradation; Patched is a receptor for the
only know ligand, Hedgehog, that has a covalently
attached cholesteryl moiety; Dispatched appears to be
involved in presenting or processing that ligand; and the
Neimann-Pick C1 protein is important for intracellular
movement of endocytosed cholesterol. 
These disparate connections to cholesterol do not imme-
diately suggest a unified action for the sterol-sensing
domain. Most popular is the model that the sterol-sensing
domain serves as a sterol-binding site, the ligation of
which causes protein-specific consequences — such as
transport, degredation, ligand binding or presentation, or
sterol transport. Alternatively, the sterol-sensing domain
might allow a protein to respond to some sterol-sensitive
features of the membrane, or perhaps it interacts with as
yet undiscovered sterol-binding proteins. Whatever the
mechanism of sterol-sensing domain action, the easily-
observed readout of this domains’ function provided by
sterol-regulated SCAP transport should go a long way
towards providing an understanding of this widely used
yet mysterious motif.
Perhaps the most exciting feature of this new view of
SCAP action is that it may represent a general regulation
strategy. Because the intracellular transport and localization
Figure 2
Regulating SREBP cleavage by exposure to S1P. (a) SCAP
movement to the Golgi brings SREBP along for the ride (arrow),
exposing it to S1P. SCAP movement to the Golgi is inhibited by high
sterol content (T bar). (b) Brefeldin A (BFA) induces mixing of Golgi
and ER contents, overriding SCAP-mediated, sterol control of S1P
cleavage of SREBP. (c) KDEL-modified S1P makes a visit to the Golgi
where it is activated, and then takes up residence in the ER, again
overriding regulation of SREBP cleavage.
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of proteins in the eukaryotic secretory pathway can be
brought about by small sequence modules that function
with relative autonomy from the proteins they are target-
ing, it is easy to imagine that this strategy of regulation
could be widely employed in the evolution of cellular
regulatory mechanisms. Even in prokaryotes, where
discrete secretory compartments are not maintained, there
are numerous examples of targeted localization to specific
membranes. With this in mind, it is intriguing that the
Bacillus subtilus transcription factor σK has striking similari-
ties to SREBP, undergoing regulated proteolytic activation
by an S2P homologue, SpoIVFB [21]. Considering the dis-
tance between a mammalian cell and a humble soil bac-
terium, this observation bodes well for the idea that
regulation by compartmentalization will turn out to be a
very big deal.
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